ஸ்ட்ரோக் வர இருக்கிறதா எனத் தெரிந்து கொள்ள இதோ !!
சின்சினாட்டி பரிசோதனை
மூளையின் சின்னஞ்சிறு ரத்த நாளங்களில் அடைப்பு ஏற்படும்பொழுதோ அல்லது ரத்த நாளங்கள் உட்பகுதி தடிப்பதாலோ ரத்த ஓட்டம் தடைபட்டு, அதனால் உயிர் அணுக்கள் இறக்கும் வாய்ப்பும் அதன் காரணமாக உடலின் ஒரு பகுதி, கை, கால் அசைவற்று போவதையோ, முகத்தில் கோணல் அல்லது இறுக்கம், மரத்துப்போதல் ஏற்படுகிறது. நடப்பதில் சிரமம் ஏற்படுகிறது. ஒருபக்கமாக கால் போகிறது.
ஸ்ட்ரோக் ஒருவருக்கு வரப்போகிறது என்பதை அறிந்து கொள்ள இயலுமா என்றால், முடியும் என்கிறார்கள். மருத்துவகத்துக்கு உடனடியாக அவரை அழைத்துச்சென்று
ஒரு நரம்பியல் நிபுணரின் ஆலோசனை பெறவேண்டும்.
ஸ்ட்ரோக் ஒருவருக்கு உடனடியாக வர இருக்கிறதா என்பதை கண்டுபிடிக்க மூன்று எளிய சோதனைகள்.
உடலின் கை, கால், முகம் அசைவுகளில் மாற்றம் இருப்பின், அவரை
1. வாய் விட்டு சிரிக்கசொல்லுங்கள்.
2. கைகள் இரண்டையும் மேலே தூக்கச்சொல்லுங்கள். பின் பக்கவாட்டில் கொண்டு வந்து மறுமுறை மேலே தூக்கச்சொல்லுங்கள்.
3. எளிய வாக்கியம் ஒன்றைக் கொடுத்து படிக்கச் சொல்லுங்கள்.
இந்த மூன்றினையும் அவர் செய்வதில் சிரமங்கள் ஏதும் இல்லையென்றால் ஸ்ட்ரோக் வரும் அபாயம் உடனடியாக இல்லை.
இருப்பினும் உடனடியாக, அவரை மருத்துவர் கண்காணிப்புக் கொண்டு செல்லுங்கள்.
ஒரு ஆஸ்பிரின் மாத்திரை (குறைந்த அளவு ) உதவி செய்யும் என்றாலும் மேற்கொண்டு அதனைக் கொடுப்பதா
என்பதை மருத்துவர்களே முடிவு செய்ய வேண்டும்.
For further information on this, kindly log on to:
http://www.neurologychannel.com/stroke/symptoms.shtml
Thursday, July 30, 2009
Wednesday, July 8, 2009
SOY THE NEW CHOLESTEROL DIET
The New Low-Cholesterol Diet: Soy
Versatile soy protein may lower bad fats floating in your bloodstream.
By R. Morgan Griffin
This is a
WebMD Feature
Reviewed by Brunilda Nazario, MD
PLEASE CLICK AT THE TITLE TO GET DIRECTLY INTO THE WEBSITE.
Cholesterol-soy-protein
Versatile soy protein may lower bad fats floating in your bloodstream.
By R. Morgan Griffin
This is a
WebMD Feature
Reviewed by Brunilda Nazario, MD
PLEASE CLICK AT THE TITLE TO GET DIRECTLY INTO THE WEBSITE.
Cholesterol-soy-protein
Soy protein can be a meal, a side dish, a snack, or a drink. Made
from the soybean, it's a staple of Asian diets. Yet it's largely been
the butt of jokes about hippies and vegans -- until recently. Today,
the buzz about soy is serious. Can it lower cholesterol naturally?
Some studies say yes. But, unfortunately, research shows mixed
results. We may not know the answer for years.
How Might Soy Protein Help?
A number of studies over the past decade seemed to show soy
protein could lower "bad" LDL cholesterol and triglycerides without
lowering "good" HDL cholesterol. Researchers aren't exactly sure how
soy protein might help. It could be a combination of the effect of the
protein and natural chemicals in soy called isoflavones. But in January
2006, the American Heart Association announced some surprising
news. A review of 22 clinical studies concluded that eating soy-based
foods has only minimal impact on cholesterol and other heart-disease
risk factors.
Until further research clears up the controversy, should you dump soy
from your diet? Not at all, says Tufts University nutrition researcher
Alice Lichtenstein, DSc, who helped write the AHA statement. "Soy
is a great food. It is low in saturated fat and it is a good-quality
protein," she says -- even if its heart benefits are less than
expected.
Conflicting Evidence on Soy
There have been many studies of the effects of soy on cholesterol.
One major article published in TheNew England Journal of Medicine
found that replacing animal protein with soy protein could lower levels
of total cholesterol, bad LDL cholesterol, and triglycerides. At the
same time, it didn't significantly lower levels of "good" HDL
cholesterol.
Some studies have shown that soy protein, when eaten along with
other cholesterol-lowering foods, can have a big effect. In a study
published in the American Journal of Clinical Nutrition in 2005,
researchers tested cholesterol-lowering drugs against cholesterol-
lowering foods in a group of 34 adults with high cholesterol. People
ate 50 grams of soy protein daily along with other cholesterol-
lowering foods. The results were striking: the diet lowered cholesterol
levels about as well as cholesterol drugs.
However, not all studies agree. An analysis of various studies led by
the U.S. Agency for Healthcare Research and Quality found that soy
had a modest effect on cholesterol levels. Researchers found that
eating a high amount of soy -- equal to about a pound of tofu a day
-- only added up to a 3% reduction in "bad" cholesterol levels.
Based on those more recent studies, the AHA Nutrition Committee no
longer recommends eating soy specifically to lower cholesterol.
However, the AHA does consider soy burgers and other soy foods a
healthy replacement for high-fat meats
There are almost endless ways of getting soy into your meal plan.
Here's a rundown of some of your options.
* Tofu is a solid extract of soybeans. "It has a mild, bean-like
flavor," says Ruth Frechman, RD, a spokeswoman for the American
Dietetic Association (ADA.) "It can be added to anything you cook or
It can be eaten right out of the package." Tofu is often used in stir
-fries, curries, or stews. It tends to pick up the flavor of the sauce
it's in.
* Soy nuts are roasted soybeans, which can make a tasty snack.
"Soy nuts are a convenient, crunchy source of protein," Frechman
tells WebMD.
* Soymilk is made from ground soybeans mixed with water. You
can substitute soymilk for milk in your coffee or your cereal. Or you
can just drink it on its own. "A lot of my clients really like smoothies
made with soy milk," says ADA spokeswoman Suzanne Farrell, MS,
RD. "That's a great way to get soy into your diet."
* Soy burgers, soy cheese, and other products now fill the
freezers and refrigerators at your local supermarket. Manufacturers
have come up with soy products that mimic just about every kind of
meat and dairy product. Buy a few different types and give them a
try.
* Edamame are soybeans still in the pod. They're sold either
frozen or fresh. Frechman recommends microwaving frozen edamame
in a little water and chicken bouillon for an easy way to get soy
protein.
* Tempeh is a fermented soybean cake. It can be used as a meat
substitute, and works well in spaghetti sauce.
* Miso is a paste made from soybeans that is used for soup
stocks or as a seasoning.
* Soy flour is a powder made from ground, roasted soybeans. It
can be added to baked goods.
Choose the foods that you like. The key is to substitute soy for
high-fat meats, such as hamburger.
Originally published September 2005.
Medically updated January 2006.
from the soybean, it's a staple of Asian diets. Yet it's largely been
the butt of jokes about hippies and vegans -- until recently. Today,
the buzz about soy is serious. Can it lower cholesterol naturally?
Some studies say yes. But, unfortunately, research shows mixed
results. We may not know the answer for years.
How Might Soy Protein Help?
A number of studies over the past decade seemed to show soy
protein could lower "bad" LDL cholesterol and triglycerides without
lowering "good" HDL cholesterol. Researchers aren't exactly sure how
soy protein might help. It could be a combination of the effect of the
protein and natural chemicals in soy called isoflavones. But in January
2006, the American Heart Association announced some surprising
news. A review of 22 clinical studies concluded that eating soy-based
foods has only minimal impact on cholesterol and other heart-disease
risk factors.
Until further research clears up the controversy, should you dump soy
from your diet? Not at all, says Tufts University nutrition researcher
Alice Lichtenstein, DSc, who helped write the AHA statement. "Soy
is a great food. It is low in saturated fat and it is a good-quality
protein," she says -- even if its heart benefits are less than
expected.
Conflicting Evidence on Soy
There have been many studies of the effects of soy on cholesterol.
One major article published in TheNew England Journal of Medicine
found that replacing animal protein with soy protein could lower levels
of total cholesterol, bad LDL cholesterol, and triglycerides. At the
same time, it didn't significantly lower levels of "good" HDL
cholesterol.
Some studies have shown that soy protein, when eaten along with
other cholesterol-lowering foods, can have a big effect. In a study
published in the American Journal of Clinical Nutrition in 2005,
researchers tested cholesterol-lowering drugs against cholesterol-
lowering foods in a group of 34 adults with high cholesterol. People
ate 50 grams of soy protein daily along with other cholesterol-
lowering foods. The results were striking: the diet lowered cholesterol
levels about as well as cholesterol drugs.
However, not all studies agree. An analysis of various studies led by
the U.S. Agency for Healthcare Research and Quality found that soy
had a modest effect on cholesterol levels. Researchers found that
eating a high amount of soy -- equal to about a pound of tofu a day
-- only added up to a 3% reduction in "bad" cholesterol levels.
Based on those more recent studies, the AHA Nutrition Committee no
longer recommends eating soy specifically to lower cholesterol.
However, the AHA does consider soy burgers and other soy foods a
healthy replacement for high-fat meats
There are almost endless ways of getting soy into your meal plan.
Here's a rundown of some of your options.
* Tofu is a solid extract of soybeans. "It has a mild, bean-like
flavor," says Ruth Frechman, RD, a spokeswoman for the American
Dietetic Association (ADA.) "It can be added to anything you cook or
It can be eaten right out of the package." Tofu is often used in stir
-fries, curries, or stews. It tends to pick up the flavor of the sauce
it's in.
* Soy nuts are roasted soybeans, which can make a tasty snack.
"Soy nuts are a convenient, crunchy source of protein," Frechman
tells WebMD.
* Soymilk is made from ground soybeans mixed with water. You
can substitute soymilk for milk in your coffee or your cereal. Or you
can just drink it on its own. "A lot of my clients really like smoothies
made with soy milk," says ADA spokeswoman Suzanne Farrell, MS,
RD. "That's a great way to get soy into your diet."
* Soy burgers, soy cheese, and other products now fill the
freezers and refrigerators at your local supermarket. Manufacturers
have come up with soy products that mimic just about every kind of
meat and dairy product. Buy a few different types and give them a
try.
* Edamame are soybeans still in the pod. They're sold either
frozen or fresh. Frechman recommends microwaving frozen edamame
in a little water and chicken bouillon for an easy way to get soy
protein.
* Tempeh is a fermented soybean cake. It can be used as a meat
substitute, and works well in spaghetti sauce.
* Miso is a paste made from soybeans that is used for soup
stocks or as a seasoning.
* Soy flour is a powder made from ground, roasted soybeans. It
can be added to baked goods.
Choose the foods that you like. The key is to substitute soy for
high-fat meats, such as hamburger.
Originally published September 2005.
Medically updated January 2006.
Wednesday, June 17, 2009
LAZARUS SYNDROME
Man comes back to life half an hour after dying-->
Fri, Jun 12 04:20 PM
London, June 12 (ANI): In a rare example of a phenomenon known as Lazarus Syndrome, a 23-year-old man came back to life 30 minutes after doctors pronounced him dead.
ctors at the Royal Preston Hospital declared Michael Wilkinson dead on February 1.
However, half an hour later, doctors realised that his pulse had returned, reports the Telegraph.
Wilkinson survived for two days before being pronounced dead a second time.
An inquest heard that his return to life was known as Lazarus syndrome - the spontaneous return of circulation after attempts to resuscitate fail.
There have only ever been 38 cases recorded worldwide.
The syndrome takes its name from the biblical story of Lazarus, who was raised from the dead by Jesus.
John Whittaker, a consultant at the Royal Preston's accident and emergency department, said it was "not a small thing" to pronounce a patient dead. "You make absolutely certain," he added.
Wilkinson had collapsed after an evening in which he had enjoyed a number of drinks with his family.
However, tests showed that alcohol played no part in the incident.
A post mortem conducted at the Royal Blackburn Hospital found that he had an undiagnosed heart condition in which his left ventricle had become abnormally thickened. (ANI)
ANI
Fri, Jun 12 04:20 PM
London, June 12 (ANI): In a rare example of a phenomenon known as Lazarus Syndrome, a 23-year-old man came back to life 30 minutes after doctors pronounced him dead.
ctors at the Royal Preston Hospital declared Michael Wilkinson dead on February 1.
However, half an hour later, doctors realised that his pulse had returned, reports the Telegraph.
Wilkinson survived for two days before being pronounced dead a second time.
An inquest heard that his return to life was known as Lazarus syndrome - the spontaneous return of circulation after attempts to resuscitate fail.
There have only ever been 38 cases recorded worldwide.
The syndrome takes its name from the biblical story of Lazarus, who was raised from the dead by Jesus.
John Whittaker, a consultant at the Royal Preston's accident and emergency department, said it was "not a small thing" to pronounce a patient dead. "You make absolutely certain," he added.
Wilkinson had collapsed after an evening in which he had enjoyed a number of drinks with his family.
However, tests showed that alcohol played no part in the incident.
A post mortem conducted at the Royal Blackburn Hospital found that he had an undiagnosed heart condition in which his left ventricle had become abnormally thickened. (ANI)
ANI
Sunday, June 14, 2009
MONTELUKAST SODIUM AGAIN IN NEWS..!
FDA Updates Singulair Label For Neuropsychiatric Events By Jennifer Corbett Dooren
Of DOW JONES NEWSWIRES
WASHINGTON (Dow Jones)--The U.S. Food and Drug Administration said Friday it was updating the label of Merck & Co.'s (MRK) Singulair and similar asthma medications to discuss reports of neuropsychiatric events such as agitation, depression, insomnia and suicidal thinking.
The new labeling will apply to Accolate, by AstraZeneca PLC (AZN), and Zyflo, by Cornerstone Therapeutics Inc. (CRTX). All three products fall into a drug class known as leukotriene modifiers. Leukotrienes are chemicals the body releases in response to an inflammatory stimulus such as breathing in an allergen.
The FDA said in a posting on its Web site that "patients and healthcare professionals should be aware of the potential for neuropsychiatric events with these medications."
Singulair, first approved in the U.S. in 1998, is Merck's top-selling product and had $4.3 billion in sales in 2008 and is the dominant drug in its class. The product is approved for use in children and adults as an asthma and allergy treatment. Accolate and Zyflo are approved as asthma treatments.
In a statement, Merck said it was "confident in the efficacy and safety of Singulair" and that it would work with the FDA to revise the label.
Merck noted it previously updated the post-marketing section of Singulair's label to discuss post-marketing reports of neuropsychiatric events.
The FDA said it requested manufacturers to include a precaution in the drug-prescribing information discussing such events, which is considered a strengthening of Singulair's current label and new information on the other two drug labels.
The FDA announced a safety review of Singulair last year after receiving reports of mood and behavior changes in patients who used Singulair. The agency asked Merck and the other two drug makers to submit all available clinical trial information, which the agency reviewed along with post-marketing reports.
The agency said some of the post-marketing reports involving neuropsychiatric events "included clinical details consistent with a drug-induced effect."
The FDA said reported neuropsychiatric events include agitation, aggression, anxiousness, dream abnormalities and hallucinations, depression, insomnia, irritability, restlessness, suicidal thinking and behavior, suicides and tremor. The agency said neuropsychiatric events "were not commonly observed" in the clinical trial data submitted by the manufacturers, but said the studies weren't designed to look for such events. The agency said sleep disorders such as insomnia were reported more frequently in clinical studies of all three drugs compared to patients taking placebos.
-By Jennifer Corbett Dooren, Dow Jones Newswires; 202-862-9294; jennifer.corbett@dowjones.com
Of DOW JONES NEWSWIRES
WASHINGTON (Dow Jones)--The U.S. Food and Drug Administration said Friday it was updating the label of Merck & Co.'s (MRK) Singulair and similar asthma medications to discuss reports of neuropsychiatric events such as agitation, depression, insomnia and suicidal thinking.
The new labeling will apply to Accolate, by AstraZeneca PLC (AZN), and Zyflo, by Cornerstone Therapeutics Inc. (CRTX). All three products fall into a drug class known as leukotriene modifiers. Leukotrienes are chemicals the body releases in response to an inflammatory stimulus such as breathing in an allergen.
The FDA said in a posting on its Web site that "patients and healthcare professionals should be aware of the potential for neuropsychiatric events with these medications."
Singulair, first approved in the U.S. in 1998, is Merck's top-selling product and had $4.3 billion in sales in 2008 and is the dominant drug in its class. The product is approved for use in children and adults as an asthma and allergy treatment. Accolate and Zyflo are approved as asthma treatments.
In a statement, Merck said it was "confident in the efficacy and safety of Singulair" and that it would work with the FDA to revise the label.
Merck noted it previously updated the post-marketing section of Singulair's label to discuss post-marketing reports of neuropsychiatric events.
The FDA said it requested manufacturers to include a precaution in the drug-prescribing information discussing such events, which is considered a strengthening of Singulair's current label and new information on the other two drug labels.
The FDA announced a safety review of Singulair last year after receiving reports of mood and behavior changes in patients who used Singulair. The agency asked Merck and the other two drug makers to submit all available clinical trial information, which the agency reviewed along with post-marketing reports.
The agency said some of the post-marketing reports involving neuropsychiatric events "included clinical details consistent with a drug-induced effect."
The FDA said reported neuropsychiatric events include agitation, aggression, anxiousness, dream abnormalities and hallucinations, depression, insomnia, irritability, restlessness, suicidal thinking and behavior, suicides and tremor. The agency said neuropsychiatric events "were not commonly observed" in the clinical trial data submitted by the manufacturers, but said the studies weren't designed to look for such events. The agency said sleep disorders such as insomnia were reported more frequently in clinical studies of all three drugs compared to patients taking placebos.
-By Jennifer Corbett Dooren, Dow Jones Newswires; 202-862-9294; jennifer.corbett@dowjones.com
Subscribe to:
Posts (Atom)